Skin manifestations of graft versus host disease;Manifestations cutanees de la reaction du greffon contre l'hote

Annales de Dermatologie et de Venereologie

Volumn 125, Issue 9, 1998, Pages 620-627

  Aractingi, S ^a,b   Carosella, E D ^b   Gluckman, E ^c  

^a HÔPITAL TENON   (France)

^b Inst Univ d'Hématologie   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DERMADROME; DISEASE CLASSIFICATION; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; SKIN BIOPSY; ACUTE DISEASE; BIOPSY; CHRONIC DISEASE; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; MOUTH DISEASE; PATHOLOGY; REVIEW; RISK FACTOR; SKIN DISEASE;

ACUTE DISEASE; BIOPSY; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; HUMANS; MOUTH DISEASES; RISK FACTORS; SKIN DISEASES;

EID: 0032153657     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Billingham R. The biology of graft versus host reactions. Harvey Lectures 1966;62:21-73.
2. Atkinson K, Chronic graft-versus-host disease. Bone Marrow Transplant 1990;5:69-82.
3. Korngold R, Sprent J. T cell subsets in graft versus host disease, in Graft versus Host Disease; Ferrara J, Deeg J, Burakoff S eds. Marcel Dekker; New York 1991:31-49.
4. Martin P, Hansen J, Buckner C, Sanders J, Deeg H, Stewart P et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985;66:664-8.
5. Reinsmoen N, Kersey J, Bach F. Detection of HLA restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions. Human Immunol 1984;11:249-57.
6. Kasten-Sportes C, Masset M, Varrin F, Devergie A, Gluckman E. Phenotype and function of T lymphocytes infiltrating the skin during graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1989;47:621-4.
7. Gaschet J, Mahé B, Milpied N, Devilder M, Dréno B, Bignon J et al. Specifity of T cells invading the skin during acute graft-versus-host disease after semiallogeneic bone marrow transplantation. J Clin Invest 1993;91:12-20.
8. Perreault C, Décary F, Brochu S, Gyger M, Bélanger R, Roy D. Minor histocompatibility antigens. Blood 1990; 76: 1269-80.
9. Goulmy E, Gratama J, Blokland E, Zwaan F, Van Rood J. A minor transplantation antigen detected by MHC-restristed cytotoxic T lymphocytes during graft-versus-host disease. Nature 1983;302:159-61.
10. Den Haan J, Sherman N, Blokland E, Huczsko E, Korning F. Wouter Drijfhout J et al. Identification of a graft-versus-host disease-associated human minor histocompatibility antigen. Science 1995;268:1476-80.
11. Ferrara J, Deeg H. Graft-versus-host disease. N Engl J Med 1991;324:667-74.
12. Volc-Platzer B, Stingl G. Cutaneous graft versus host disease, in Graft versus Host Disease; Ferrara J, Deeg J, Burakoff S eds. Marcel Dekker, New York 1991:245-54.
13. Friedman K, LeBoit P, Farmer R. Acute follicular graft versus host disease. A distinct clinico-pathologic presentation. Arch Dermatol 1988;124:688-91.
14. Villada G, Roujeau J, Cordonnier C, Bagot M; Kuentz M, Wexchsler J et al. Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases. J Am Acad Dermatol 1990;23:870-5.
15. Sloane J. Graft-versus-host disease. A histological perspective. Blood 1990;4:196-203.
16. Murphy G, Whitaker D, Sprent J, Korngold R. Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4 + or CD8 + effector cells. Am J Pathol 1991;138:983-90.
17. Sale G, Beauchamp M. The parafollicular hair bulge in human GvHD: a stem cell rich primary target. Bone Marrow Transplant 1993;11:223-5.
18. Gilliam A, Whitaker-Menezes D, Korngold R, Murphy G. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft versus host disease. J Invest Dermatol 1996;107:377-83.
19. Langley R, Walsch N, Nevill T, Thomas L, Rowden G. Apoptosis is the mode of kerationocyte death in cutaneous graft versus host disease. J Am Acad Dermatol 1996;35:187-90.
20. Acevedo A, Aramburu J, Lopez J, Fernandez-Herrera J, Fernandez-Ranada J, Lopez-Botet M. Identification of natural killer (NK) cells in lesions of human cutaneous graft-versus-host disease: Expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates. J Invest Dermatol 1991;97:659-66.
21. Elliott C, Sloane J, Pallett C, Sanderson K. Cutaneous leucocyte composition after human allogeneic bone marrow transplantation: relationship to marrow purging, histology and clinical rash. Histopathology 1988;12:1-16.
22. Tsoi M, Storb R, Jones E, Weiden P, Shulman H, Witherspoon R et al. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-versus-host disease in man. J Immunol 1978;120:1485-92.
23. Sale G, Lerner K, Barker E, Shulman H, Thomas E. The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol 1977;89:621-36.
24. Drijkoningen M, De Wolff-Peters C, Tricot G, Degreef H, Desmet V. Drug induced skin reactions and acute graft versus host disease: a comparative immunohistochemical study. Blut 1988;56:69-73.
25. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yasaki T, Sobue R et al. Human herpes virus 6 infection in bone marrow transplantation. Blood 1991;78:1381-4.
26. Tsoi M, Storb R, Dobbs S, Medill L, Thomas D. Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-versus-host disease. J Immunol 1980;125:2258-62.
27. Van Els C, Bakker A, Zwinderman A, Zwaan F, Van Rood J, Goulmy E. Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. Absence of correlation with cytotoxic effector cells. Transplantation 1990;50:62-6.
28. Bunjes D, Theobald M, Nierle T, Arnold R, Heimpel H. Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease. Bone Marrow Transplant 1995; 15:727-32.
29. Anasetti C, Rybka W, Sullivan K, Banaji M, Slichter S. Graft-versus-host disease is associated with autoimmune-like thrombocytopenia. Blood 1989;73:1054-8.
30. Graze P, Gale R. Chronic graft-versus-host disease: A syndrome of disordered immunity. Am J Med 1979;66:611-20.
31. Wesierska-Gadek J, Penner E, Hitchman E, Kier P, Sauermann G. Nucleolar proteins B23 and C23 as target antigens in chronic graft-versus-host disease. Blood 1992;79:1081-6.
32. Parkman R. Clonal analysis of murine graft-versus-host disease. I Phenotypic and functional analysis of T lymphocyte clones. J Immunol 1986;136:3543-8.
33. Storb R, Prentice R, Sullivan K, Shulman H, Deeg H, Doney K et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 1983;98:461-6.
34. Saurat J, Gluckman E, Bussel A, Didierjean L, Puissant A. The lichen planus-like eruption after bone marrow transplantation. Br J Dermatol 1975;92:675.
35. Touraine R, Revuz J, Dreyfus B, Rochant H, Mannoni P. Graft versus host reaction and lichen planus. Br J Dermatol 1975;92:589.
36. Beers B, Kalish R, Kaye V, Dahl M. Unilateral linear lichenoid eruption after bone marrow transplantation: an unmasking of tolerance to an abnormal keratinocyte clone ? J Am Acad Dermatol 1993;28:888-92.
37. Chosidow O, Bagot M, Vemant J, Touraine R, Cordonnier C, Revuz J. Sclerodermatous chronic graft versus host disease. J Am Acad Dermatol 1992;26:49-55.
38. Aractingi S, Socié G, Devergie A, Dubertret, Gluckman E. Localized scleroderma like lesions on the legs in bone marrow transplant recipents: association with polyneuropathy in the same distribution. Br J Dermatol 1993;129:201-3.
39. Hymes S, Farmer E, Burns W, Morison W, Tutschka P, Walters L et al. Bullous scleroderma-like changes in chronic graft-versus-host disease. Arch Dermatol 1985;121:1189-92.
40. Janin-Mercier A, Socié G, Devergie A, Aractingi S, Esperou H, Verola O et al. Fasciitis in chronic graft versus host disease. Ann Int Med 1994;120:993-8.
41. Schubert M, Sullivan K, Morton T, Izutsu K, Peterson D, Flournoy N et al. Oral manifestations of chronic graft-versus-host disease. Arch Intern Med 1984; 144:1591-5.
42. Gratwhol A, Moutsopoulos H, Chused T, Akizuki M, Wolf R, Sweet J et al. Sjögren type syndrome after allogeneic bone marrow transplantation. Ann Intern Med 1977;87:703-6.
43. Shulman H, Sale G, Lerner K, Barker E, Weiden P, Sullivan K et al. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978;92:545-70.
44. Janin Mercier A, Saurat J, Bourges J, Sohier J, Jean L, Gluckman E. The lichen planus like and sclerotic phases of the graft versus host disease in man: an ultrastructural study of six cases. Acta Dermatol Venereol (Stockh) 1981;61:187-93.
45. Sullivan K, Shulman H, Storb R, Weiden P, Witherspoon R, McDonald P et al. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981;57:267-6.
46. Sullivan K, Witherspoon R, Storb R, Weiden P, Flournoy N, Dahlberg S et al. Prednisone and azathioprine compared to prednisone and placebo for treatment of chronic graft-versus host disease: Prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988;72:546.
47. Shulman H, Sullivan K, Weiden P, McDonald P, Striker G, Sale G et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
48. Atkinson K, Farewell V, Tsoi M, Sullivan K, Witherspoon R, Thomas E et al. Analysis of late infections after human bone marrow transplantation. Role of non-specific suppressor cells in patients with chronic graft-versus-host disease and genotypic non identity between marrow donor and recipient. Blood 1982;60:714-20.
49. Socić G, Henry-Amar M, Bacigalupo A, Hous J, Tichelli A, Ljungran P et al. Malignant tumors occuring after treatment of aplastic anemia. European hone marrow transplantation severe aplastic anemia working party. N Engl J Med 1993;329:1152-7.
50. Curtis R, Rowlings P, Deeg H, Shriner DA, Socié G, Travis LB Solid cancers after bone marrow transplantation. N Engl J Med 1997;336:897-904.
51. Weiden P, Sullivan K, Flournoy N, Storb R, Thomas E. The Seattle marrow transplant team: Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981;304: 1529.